Saratoga Health & Biotechnology Portfolio C (SHPCX)
14.26
+0.28
(+2.00%)
USD |
Apr 08 2026
SHPCX Asset Allocations & Exposures
Asset Allocation
As of February 28, 2026.
| Type | % Net |
|---|---|
| Cash | 1.16% |
| Stock | 97.78% |
| Bond | 1.39% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.32% |
Market Capitalization
As of February 28, 2026
| Large | 55.12% |
| Mid | 23.84% |
| Small | 21.04% |
Region Exposure
| Americas | 86.11% |
|---|---|
|
North America
|
86.11% |
| United States | 86.11% |
|
Latin America
|
0.00% |
As of February 28, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 13.06% |
|---|---|
| United Kingdom | 0.00% |
|
Europe Developed
|
13.06% |
| Denmark | 0.56% |
| Ireland | 7.93% |
| Switzerland | 4.56% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 0.83% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
97.48% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
97.48% |
| Utilities |
|
0.00% |
| Not Classified |
|
2.52% |
| Non Classified Equity |
|
0.00% |
| Not Classified - Non Equity |
|
2.52% |
As of February 28, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |